We believe that systemic immune-inflammation index and lymphocyte–monocyte ratio values measured in the first-trimester complete blood count parameters are effective in predicting gestational diabetes mellitus but are not effective in determining insulin requirement. This evidence concerns the gene INS and gestational diabetes.